Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ISRCTN24140407) titled 'A trial looking at metformin for early prostate cancer patients undergoing surgery' on Sept. 17.
Study Type: Interventional
Study Design:
Allocation: Randomized controlled trial
Masking: Blinded (masking used)
Control: Placebo
Assignment: Parallel
Purpose: Basic science, Treatment
Primary Sponsor: Guy's and St Thomas' NHS Foundation Trust
Condition:
Prostate cancer
Cancer
Intervention:
Participants with a confirmed diagnosis of prostate cancer, who meet the inclusion criteria and none of the exclusion criteria, will provide informed consent and enter screening. Once eligibility is confirmed, they will then...